RBC Bioscience Corporation (6848.TWO)
TWD 18.0
(-9.09%)
TWD 18.0
(-9.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 58.35 Million TWD | -10.87% |
| 2022 | 65.35 Million TWD | -5.05% |
| 2021 | 68.83 Million TWD | -38.51% |
| 2020 | 111.94 Million TWD | 473.54% |
| 2019 | 19.51 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 15.35 Million TWD | 0.92% |
| 2024 Q1 | 15.21 Million TWD | 13.32% |
| 2023 Q1 | 14.26 Million TWD | -0.95% |
| 2023 Q4 | 13.42 Million TWD | 0.0% |
| 2023 Q2 | 14.26 Million TWD | 0.0% |
| 2023 FY | 58.24 Million TWD | -10.87% |
| 2023 Q3 | 13.42 Million TWD | -5.91% |
| 2022 Q3 | 14.4 Million TWD | 0.0% |
| 2022 FY | 65.35 Million TWD | -5.05% |
| 2022 Q4 | 14.4 Million TWD | 0.0% |
| 2021 FY | 68.83 Million TWD | -38.51% |
| 2020 FY | 111.94 Million TWD | 473.54% |
| 2019 FY | 19.51 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -17637.386% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 54.292% |
| Level Biotechnology Inc. | 151.99 Million TWD | 61.606% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 57.045% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 23.073% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 74.091% |
| GlycoNex Incorporation | 995 Thousand TWD | -5764.925% |
| VBI | 32.55 Million TWD | -79.254% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 77.282% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 69.948% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -26.797% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 51.334% |
| Visgeneer Inc. | 67.48 Million TWD | 13.524% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 115.554% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 88.56% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 8.68% |
| Neith Corporation | 66.87 Million TWD | 12.736% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 95.959% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -98.814% |
| Enimmune corporation | 220.1 Million TWD | 73.487% |
| TaiRx, Inc. | 217.13 Million TWD | 73.124% |
| CHO Pharma, Inc. | 268.99 Million TWD | 78.306% |
| EirGenix Inc. | 236.74 Million TWD | 75.35% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 44.077% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 83.682% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 94.68% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 78.075% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -17.96% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -5288.366% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 67.114% |
| BiOptic Inc. | 108.69 Million TWD | 46.311% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -64740.0% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 15.853% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2131.587% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 90.937% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 37.478% |
| NaviFUS Corp. | 11.82 Million TWD | -393.413% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 69.404% |
| Sinew Pharma Inc. | 186.25 Million TWD | 68.668% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 21.165% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 73.522% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -40.681% |
| AP Biosciences Inc | 32.25 Million TWD | -80.932% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 96.846% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -1006.485% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 81.61% |
| Intech Biopharm Corporation | -163.99 Million TWD | 135.584% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 94.832% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -40.678% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 65.583% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 60.308% |
| TCI GENE Inc. | 174.61 Million TWD | 66.581% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -324100.0% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 80.609% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 79.943% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 30.483% |
| PharmaEngine, Inc. | 441.78 Million TWD | 86.791% |
| Savior Lifetec Corporation | 223.36 Million TWD | 73.875% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 77.449% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 97.106% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 57.978% |
| Acepodia, Inc. | 452.56 Million TWD | 87.106% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 89.212% |